- Liver Transplant Medicine
- Non-alcoholic Fatty Liver Disease
Dr. Erin Spengler is the Co-Director of the Metabolic Liver Health Clinic (MLHC) for comprehensive non-alcoholic fatty liver disease (NAFLD) care. She graduated medical school with Service Distinction, which recognizes people who work extensively to improve care for medically underserved, marginalized and rural populations. She dedicated much of these efforts to the care of Spanish-speaking migrant workers and victims of domestic violence.
She has more than 15 publications in peer-reviewed medical journals and is the author of two book chapters on liver disease. Her publications and research efforts focus primarily on the care of patients with NAFLD, the management of portal hypertension and the outcomes of non-traditional liver transplant recipients. She remains involved in several multi-center research consortia and has been invited to present her research at national conferences.
She has held regional and national leadership positions, and served on the Communications and Technology Committee of the American Association for the Study of Liver Diseases (AASLD) as well as the Executive Committee of the American Society of Transplantation (AST) Liver and Intestinal Community of Practice (LICOP).
Dr. Spengler's clinic interests include advanced liver disease, using hepatopathology, diagnostic testing and medical interventions to diagnose and treat her patients. She feels the most successful medical outcomes require patient education, mutual respect and open communication. Dr. Spengler’s clinical interests also include transplant medicine, advanced hepatology and non-alcoholic fatty liver disease (NAFLD).
Education & credentials
- Internal Medicine
- Transplant Hepatology
- University of Iowa Carver College of Medicine, Iowa City, IA
Gastroenterology and Hepatology, University of Iowa Hospital and Clinics, Iowa City, IA
Transplant Hepatology, University of Michigan Hospitals, Ann Arbor, MI
- University of Iowa Hospitals and Clinics, Iowa City, IA